Pharmacokinetic-Pharmacodynamic Characterization of Omadacycline against Haemophilus influenzae Using a One-Compartment In Vitro Infection Model

Omadacycline is a novel aminomethylcycline with activity against Gram-positive and -negative organisms, including Haemophilus influenzae, which is one of the leading causes of community-acquired bacterial pneumonia (CABP). The evaluation of antimicrobial agents against H. influenzae using standard m...

Descripción completa

Detalles Bibliográficos
Autores principales: VanScoy, Brian D., Lakota, Elizabeth A., Conde, Haley, McCauley, Jennifer, Friedrich, Lawrence, Steenbergen, Judith N., Ambrose, Paul G., Bhavnani, Sujata M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269464/
https://www.ncbi.nlm.nih.gov/pubmed/32284378
http://dx.doi.org/10.1128/AAC.02265-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269464/
https://www.ncbi.nlm.nih.gov/pubmed/32284378
http://dx.doi.org/10.1128/AAC.02265-19

Ejemplares similares